Postpartum depression affects one in seven women. In March, the Food and Drug Administration approved the first drug specifically for postpartum depression. A month earlier, the U.S. Preventive Services Task Force released new guidelines recommending screening for depression in all pregnant and postpartum women and referring those at risk to counseling.
But those advances help only if women in need are identified in the first place — a particular challenge for women of color and low-income moms, research shows, as they are several times more likely to suffer from postpartum mental illness, but less likely to receive treatment.
Read Full Article Here: www.philly.com
Photo Credit: Staff Photographers, Tom Gralish and Rachel Wisniewski